Oral Immunotherapy With Partially Hydrolyzed Wheat-Based Cereals: A Pilot Study
To date, only few studies have assessed oral immunotherapy (OIT) for wheat allergy and often describe severe adverse reactions during therapy. We developed partially hydrolyzed wheat-based cereals (pHC), which were used in a multicenter, open-label, OIT pilot study, in immunoglobulin E–mediated whea...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-09-01
|
Series: | Clinical Medicine Insights: Pediatrics |
Online Access: | https://doi.org/10.1177/1179556517730018 |